Literature DB >> 7688009

High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies.

J F Quaranta, A Tran, D Régnier, R Letestu, C Beusnel, J G Fuzibet, V Thiers, P Rampal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7688009     DOI： 10.1016/s0168-8278(05)80022-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  9 in total

1.  Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western Sardinia.

Authors:  A Loviselli; A Oppo; F Velluzzi; F Atzeni; G L Mastinu; P Farci; G Orgiana; A Balestrieri; P L Cocco; S Mariotti
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

Review 2.  Nonhepatic manifestations and combined diseases in HCV infection.

Authors:  S J Hadziyannis
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

3.  Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.

Authors:  N Custro; G Montalto; V Scafidi; M Soresi; S Gallo; S Tripi; A Notarbartolo
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

Review 4.  Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens.

Authors:  P Obermayer-Straub; M P Manns
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

5.  Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States.

Authors:  Manal M Hassan; Ahmed Kaseb; Donghui Li; Yehuda Z Patt; Jean-Nicolas Vauthey; Melanie B Thomas; Steven A Curley; Margaret R Spitz; Steven I Sherman; Eddie K Abdalla; Marta Davila; Richard D Lozano; Deena M Hassan; Wenyaw Chan; Thomas D Brown; James L Abbruzzese
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

6.  Expression of endocrine autoantibodies in chronic hepatitis C, before and after interferon-alpha therapy.

Authors:  G Murdolo; D Francisci; F Forini; F Baldelli; G Angeletti; G Stagni; F Santeusanio; F Calcinaro; A Falorni
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

Review 7.  Immunological alterations in hepatitis C virus infection.

Authors:  Vincenza Calvaruso; Antonio Craxì
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 8.  Autoimmune manifestations in viral hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  Semin Immunopathol       Date:  2012-07-28       Impact factor: 11.759

9.  Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis.

Authors:  Jason T Blackard; Ling Kong; Amanda K Huber; Yaron Tomer
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.